P. Foerch

发表

Rare and common epilepsies converge on a shared gene regulatory network providing opportunities for novel antiepileptic drug discovery

Michael R. Johnson, Sarah R. Langley, E. Petretto, 2016, Genome Biology.

Genome-wide analysis of differential RNA editing in epilepsy.

Michael R. Johnson, Sarah R. Langley, E. Petretto, 2017, Genome research.

Systems genetics identifies a convergent gene network for cognition and neurodevelopmental disease

Doug Speed, Mario Falchi, Enrico Petretto, 2015, Nature Neuroscience.

Combining modelling and mutagenesis studies of synaptic vesicle protein 2A to identify a series of residues involved in racetam binding.

Jiye Shi, B. Lynch, P. Foerch, 2011, Biochemical Society transactions.

Comparative study of lacosamide and classical sodium channel blocking antiepileptic drugs on sodium channel slow inactivation

P. Foerch, Christian Wolff, C. Vandenplas, 2013, Journal of neuroscience research.

Determining the Relative Efficacy of Positive Allosteric Modulators of the GABAA Receptor

P. Foerch, P. Ghisdal, E. Hanon, 2014, Journal of biomolecular screening.

Expression of SV2 isoforms during rodent brain development

G. Moonen, P. Foerch, B. Rogister, 2013, BMC Neuroscience.

Rare and common epilepsies converge on a shared gene regulatory network providing opportunities for novel antiepileptic drug discovery

Michael R. Johnson, E. Petretto, S. Petrou, 2016, Genome Biology.

Systems genetics identifies Sestrin 3 as a regulator of a proconvulsant gene network in human epileptic hippocampus

Slave Petrovski, Doug Speed, Terence J O'Brien, 2015, Nature Communications.

Differential expression of miR-184 in temporal lobe epilepsy patients with and without hippocampal sclerosis – Influence on microglial function

A. Pfeifer, D. Delev, B. Danis, 2016, Scientific Reports.

Different MicroRNA Profiles in Chronic Epilepsy Versus Acute Seizure Mouse Models

H. Fröhlich, B. Danis, M. Mazzuferi, 2014, Journal of Molecular Neuroscience.

MTHFD2 is a metabolic checkpoint controlling effector and regulatory T cell fate and function.

J. Rabinowitz, J. Rathmell, John Karijolich, 2021, Immunity.

Anticonvulsant and antiepileptogenic effects of system xc− inactivation in chronic epilepsy models

P. Maher, Seon-Ah Chong, P. Foerch, 2019, Epilepsia.

Expression pattern of synaptic vesicle protein 2 (SV2) isoforms in patients with temporal lobe epilepsy and hippocampal sclerosis

G. Moonen, B. Sadzot, M. Mazzuferi, 2014, Neuropathology and applied neurobiology.

Changes in serum miRNAs following generalized convulsive seizures in human mesial temporal lobe epilepsy.

C. Elger, H. Fröhlich, A. Pfeifer, 2016, Biochemical and biophysical research communications.

Nrf2 defense pathway: Experimental evidence for its protective role in epilepsy

B. Danis, M. Mazzuferi, P. Foerch, 2013, Annals of neurology.

MTHFD2 is a Metabolic Checkpoint Controlling Effector and Regulatory T Cell Fate and Function

J. Rabinowitz, J. Rathmell, John Karijolich, 2021, bioRxiv.

Rapid establishment of the European Bank for induced Pluripotent Stem Cells (EBiSC) - the Hot Start experience.

Tony Burdett, Helen Parkinson, Heiko Zimmermann, 2017, Stem cell research.

Synaptic vesicle glycoprotein 2A modulates vesicular release and calcium channel function at peripheral sympathetic synapses

Benjamin J. Whalley, C. Vogl, B. Danis, 2014, The European journal of neuroscience.

A systems-level framework for drug discovery identifies Csf1R as an anti-epileptic drug target

Patrice Godard, Enrico Petretto, Prashant K. Srivastava, 2018, Nature Communications.

Different MicroRNA Profiles in Chronic Epilepsy Versus Acute Seizure Mouse Models

H. Fröhlich, A. Pfeifer, B. Danis, 2014, Journal of Molecular Neuroscience.

A Systems-Level Framework for Drug Discovery Identifies Csf1R As A Novel Anti-Epileptic Drug Target

E. Petretto, A. Delahaye-Duriez, P. Srivastava, 2017, bioRxiv.